Chardan NexTech Acquisition in its fourth amended S-1 filing lowered its proposed IPO to 15 million units, down from 20 million as initially registered with the SEC in March. A unit consists of one share and a warrant.
The SPAC remains focused on disruptive technologies in both HealthTech and FinTech.
Chardan NexTech is led by Chairman Kerry Propper, co-founder of Chardan and CEO and head of its investment bank from 2003 to 2015.
Chardan Capital Markets, the representative of the underwriters, has the option to purchase up to 2.25 million additional units to cover over-allotments, if any.
The SPAC has applied for a Nasdaq listing under CNAQU. Read more.
